PWPCM
REGN icon

Perella Weinberg Partners Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Perella Weinberg Partners Capital Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-3,160
Closed -$710K – 223
2013
Q2 		$710K Buy
+3,160
New +$736K 0.05% 175

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Perella Weinberg Partners Capital Management's REGN Position: Q3 2013 in Review

Perella Weinberg Partners Capital Management sold out of Regeneron Pharmaceuticals (REGN) in Q3 2013, closing a stake of 3,160 shares — an estimated $710K sold.

Perella Weinberg Partners Capital Management first reported a position in REGN in Q2 2013 and held it in 1 quarter. The position peaked at $710K in Q2 2013. 414 funds tracked by Wall St. Rank hold REGN as of Q3 2013.

  • Perella Weinberg Partners Capital Management reported no remaining Regeneron Pharmaceuticals position as of Q3 2013 after selling out during the quarter.
  • Perella Weinberg Partners Capital Management sold 3,160 Regeneron Pharmaceuticals shares in Q3 2013, an estimated $710K.
  • Perella Weinberg Partners Capital Management first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 1 quarter.
  • Perella Weinberg Partners Capital Management's Regeneron Pharmaceuticals position peaked at $710K in Q2 2013.
  • 414 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2013.

Based on Perella Weinberg Partners Capital Management's 13F filing for Q3 2013, filed 14 Nov 2013.